V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20069403 | 20086973 | 1.73 | 53.6 | 03 | 2018-03-27 | 2018-03-29 | CAV | 2 | N | PHITT B OR C CISPLATIN | 101010795 |
| 20069474 | 20086974 | 1.74 | 83 | 03 | 2019-12-01 | 2019-12-21 | EEF or EOF | 02 | N | POMALIDOMIDE | 100003668 |
| 20069479 | 20086975 | 1.66 | null | Palliative (P) | 2020-01-25 | 2020-01-25 | PRIMUS 002 TRIAL | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100071270 |
| 20069583 | 20086976 | 1.68 | 95.55 | Palliative (P) | 2019-06-17 | 2019-06-20 | PANTHER TRIAL | 02 | N | SCOPE2 TRIAL | 100113393 |
| 20069608 | 20086977 | 1.71 | 64.1 | Curative (C) | 2021-05-20 | 2021-05-30 | IBRUTINIB | 02 | N | RITUXIMAB | 100153357 |
| 20069745 | 20086978 | 1.66 | 68 | null | 2017-09-01 | 2017-09-10 | null | 01 | null | ACELARATE TRIAL | 100677385 |
| 20069791 | 20086979 | 0 | 0 | Palliative (P) | 2021-02-07 | 2021-02-22 | EEF or EOF | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100948501 |
| 20069962 | 20086981 | 1.78 | 84.9 | Palliative (P) | 2016-12-10 | 2016-12-15 | null | null | null | RITUXIMAB | 101791612 |
| 20070046 | 20086982 | 1.51 | 0.7 | 03 | 2018-09-09 | 2018-09-09 | CISPLATIN + TEYSUNO | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN | 101510317 |
| 20070059 | 20086983 | 1.59 | 105.2 | 03 | 2016-09-11 | 2016-09-18 | LENALIDOMIDE | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100455280 |
| 20070144 | 20086984 | 1.63 | 64.2 | 03 | 2019-11-02 | 2019-11-18 | CISPLATIN + FLUOROURACIL + RT | 02 | N | PACLITAXEL | 100276516 |
| 20070190 | 20086985 | 1.76 | 93 | Palliative (P) | 2019-12-08 | 2019-12-13 | Radium 223 | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100869083 |
| 20070233 | 20086986 | null | null | null | 2018-10-02 | 2018-10-02 | TAC | 02 | N | MCX | 100222239 |
| 20070259 | 20086987 | 1.5 | 82.8 | 03 | 2016-05-21 | 2016-06-17 | PEMBROLIZUMAB | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101470311 |
| 20070301 | 20086988 | 1.56 | 54.3 | Palliative (P) | 2018-03-01 | 2018-03-29 | Raltitrexed | N | N | BENDAMUSTINE + RITUXIMAB | 100523326 |
| 20070345 | 20086989 | null | null | Palliative (P) | 2018-06-06 | 2018-06-06 | Capecitabine + Streptozocin | 01 | N | EVEROLIMUS | 101842813 |
| 20070382 | 20086991 | 1.6 | 61 | Neo-adjuvant (N) | 2017-02-10 | 2017-02-10 | Chlorambucil | 01 | N | GEMCARBO | 100340739 |
| 20070383 | 20086992 | 1.63 | 57.5 | null | 2016-09-04 | 2016-09-04 | Fluorouracil + Folinic + RT Bossett | 01 | N | OXALIPLATIN | 100267333 |
| 20070406 | 20086993 | 1.7 | 79.8 | Palliative (P) | 2019-06-09 | 2019-06-14 | Irinotecan | 1 | N | CISPLATIN + VINORELBINE | 101067145 |
| 20070445 | 20086994 | 1.76 | 78.4 | 03 | 2017-10-01 | 2017-11-16 | STS Rhabdomyosarcoma RMS 2005 IVAVV | null | Y | CAPECITABINE + STREPTOZOCIN | 101305613 |
| 20070446 | 20086995 | 1.54 | 44 | 03 | null | 2021-02-15 | NIVOLUMAB | N | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100303847 |
| 20070491 | 20086996 | 1.72 | 74 | Palliative (P) | 2019-08-03 | 2019-08-11 | NB HRNBL-1 BUMEL MAT | 02 | N | EVEROLIMUS | 100053164 |
| 20070522 | 20086997 | 1.58 | 68 | null | 2019-01-11 | 2019-01-16 | ACELARATE Trial | 01 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100344328 |
| 20070551 | 20086998 | 1.89 | 63.45 | Palliative (P) | 2017-05-12 | 2017-05-18 | SCOPE 2 TRIAL | 02 | N | RALTITREXED | 101781978 |
| 20070652 | 20087000 | 1.52 | null | null | 2018-06-06 | 2018-06-06 | CAP + RT | 02 | Y | PACLITAXEL | 101336423 |
| 20070752 | 20087001 | 1.61 | null | Adjuvant (A) | 2019-11-05 | 2019-11-05 | Everolimus 10mg | 02 | N | EOF | 101258011 |
| 20071309 | 20087002 | 1.6 | 72.8 | 03 | 2018-04-10 | 2018-04-14 | Erlotinib | 01 | N | ARISTOTLE TRIAL | 100555555 |
| 20071495 | 20087003 | 1.59 | 74 | Neo-adjuvant (N) | 2018-05-31 | 2018-06-01 | Rituximab | 02 | N | DOXORUBICIN | 101870681 |
| 20071680 | 20087004 | 1.67 | 78 | Adjuvant (A) | 2019-01-31 | 2019-02-14 | Sunitinib | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100069084 |
| 20072600 | 20087006 | 1.87 | 85.6 | null | null | 2018-03-01 | CAPE + OXALIPLATIN + TRASTUZUMAB | Y | N | CVD | 100797625 |
| 20072741 | 20087007 | 1.63 | 88.7 | Adjuvant (A) | 2019-10-05 | 2019-10-22 | null | 02 | N | BENDAMUSTINE + RITUXIMAB | 100429207 |
| 20073014 | 20087008 | 1.81 | 55 | Adjuvant (A) | 2018-11-17 | 2018-12-03 | Cisplatin 100 + RT(H&N) 1 day | N | N | ACTICCA-1 TRIAL | 100024561 |
| 20073374 | 20087009 | 1.78 | 79.8 | null | null | 2020-03-30 | FCarboSt | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101601864 |
| 20073415 | 20087010 | 1.75 | 71.1 | 03 | 2017-07-02 | 2017-07-15 | GEM-P | N | N | PACLITAXEL | 101002134 |
| 20073763 | 20087011 | 1.47 | 82.35 | Palliative (P) | 2018-07-29 | 2018-07-29 | IPILIMUMAB + NIVOLUMAB | 02 | N | PEMBROLIZUMAB | 100780633 |
| 20074200 | 20087012 | 1.64 | 48.6 | Palliative (P) | 2018-10-05 | 2018-10-08 | FOXTROT TRIAL | 02 | N | EVEROLIMUS | 101359617 |
| 20074322 | 20087013 | 0 | 6.9 | Palliative (P) | 2018-08-01 | 2018-08-04 | Bortezomib + Panobinostat | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101752180 |
| 20074557 | 20087014 | null | 134.05 | null | 2019-09-26 | 2019-09-26 | INTERFERON | 02 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101688850 |
| 20074761 | 20087015 | 1.75 | 89.3 | Palliative (P) | 2016-01-22 | 2016-01-22 | ESPAC-4 TRIAL | 02 | N | DOCETAXEL | 101565676 |
| 20075366 | 20087016 | 0 | 0 | 03 | 2016-03-17 | 2016-03-17 | ECarboX | 02 | N | CARBOPLATIN + VINORELBINE | 100783629 |
| 20075766 | 20087017 | 1.68 | 66 | Palliative (P) | 2018-01-03 | 2018-01-10 | Bortezomib +/- Dexamethasone | 02 | N | EOF | 100506388 |
| 20075782 | 20087018 | 1.73 | 83.8 | null | 2018-11-18 | 2018-11-19 | COSMIC TRIAL | 02 | N | TEMOZOLOMIDE | 100751135 |
| 20075911 | 20087019 | 1.7 | 73.35 | 03 | 2018-09-15 | 2018-09-15 | LENALIDOMIDE | 02 | N | EVEROLIMUS | 101294242 |
| 20076681 | 20087020 | 1.64 | 92.8 | null | 2019-06-24 | 2019-06-24 | Cisplatin + Fluorouracil + RT 5day | 02 | N | LENALIDOMIDE | 101298341 |
| 20076999 | 20087021 | 1.81 | 103 | 03 | null | 2020-02-28 | FCarboSt | Y | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101533183 |
| 20077317 | 20087023 | 1.85 | 69.6 | 03 | 2017-05-20 | 2017-05-20 | CAP + RT | N | N | CISPLATIN + RALTITREXED | 101201396 |
| 20077637 | 20087024 | 1.56 | 103.6 | 03 | null | 2018-09-08 | Abiraterone | N | N | DARATUMUMAB | 100206422 |
| 20078310 | 20087025 | 1.68 | 67.8 | Adjuvant (A) | 2017-02-17 | 2017-02-17 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | N | GEMCITABINE + PACLITAXEL | 100647413 |
| 20078460 | 20087026 | 1.56 | 68.5 | Palliative (P) | 2019-01-11 | 2019-01-15 | CTD | 02 | N | SUNITINIB | 100966912 |
| 20078486 | 20087027 | 1.58 | 58.6 | Palliative (P) | 2019-03-10 | 2019-03-10 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | BORTEZOMIB + THALIDOMIDE | 100423727 |